Table of Content
1 Introduction
1.1 Definition
1.2 Scope of the study
1.2.1 Research Objectives
1.2.2 Assumptions & Limitations
1.3 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
2.4 Forecast Model
3 Report Excerpt
4 Forecast Indicators
4.1 Introduction
4.2 Growth Drivers
4.2.1 Government's Support
4.2.2 Technological advancements
4.2.3 High prevalence of UTIs
4.2.4 Rising diabetic population
4.2.5 Technological advancements
4.2.6 Players engaged in creating awareness
4.3 Growth Barriers
4.3.1 Varied regulatory stringency across globe
4.3.2 Lower rate of adoption in under developed countries
4.3.3 Inadequate reimbursement for test strips
4.4 Market Opportunities
4.4.1 Rising Point of Care
4.4.2 Rising Disposable Income Of Emerging Economies
4.5 Macroecnomical Indicators
5 Market Analysis
5.1 Marketing Mix
5.2 Porter's Five Force
5.3 Supply Chain Analysis
5.4 Value chain Analysis
6 Global Test Strip Markets, By Product Type
6.1 Introduction
6.2 Urine test strip
6.3 Diabetic Strips
6.4 Fluorescein
7 Global Test Strip Market, By Application
7.1 Introduction
7.2 Disease Diagnosis
7.2.1 Urinalysis
7.2.1.1 Urinary Tract Infection (UTI)
7.2.1.2 Liver Disease
7.2.1.3 Kidney Diseases
7.2.1.4 Diabetic Test
7.2.1.5 Others
7.2.2 Blood Glucose Analysis
7.2.3 Ophthalmic Diagnostic
7.3 Pregnancy Test
8 Global Test Strip Market, By Function
8.1 Introduction
8.2 Visual Test Strips
8.3 Automated Test Strips
9 Global Test Strip Market, By End Users
9.1 Introduction
9.2 Institutes & Research Laboratories
9.3 Hospitals & Clinics
9.4 Diagnostic Laboratories
9.5 Consumers
10 Global Test Strip Market, by Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia
10.5 Rest of the World
11 Competitive Landscape
11.1 Market Share Analysis
11.1.1 Global
11.1.2 North America
11.1.3 Europe
11.1.4 Asia-Pacific
11.1.5 Rest of the World
11.2 Competitive/Strategic Scenario
11.2.1 Mergers Acquisitions
11.2.2 Collaborations
11.2.3 Expansion
11.2.4 New Product Launches
12 Company Profiles
12.1 Introduction
12.2 Abbott Laboratories
12.2.1 Overview
12.2.2 Financials
12.2.3 Product Portfolio
12.2.4 Recent Developments
12.2.5 Business Strategies
12.3 Arkray Inc.
12.3.1 Overview
12.3.2 Financials
12.3.3 Product Portfolio
12.3.4 Recent Developments
12.3.5 Business Strategies
12.4 Ascensia Diabetes Care Holdings Ag (Previously Known As Bayer Diabetes Care)
12.4.1 Overview
12.4.2 Financials
12.4.3 Product Portfolio
12.4.4 Recent Developments
12.4.5 Business Strategies
12.5 B. Braun Melsungen AG
12.5.1 Overview
12.5.2 Financials
12.5.3 Product Portfolio
12.5.4 Recent Developments
12.5.5 Business Strategies
12.6 Chiltern Medicare Ltd
12.6.1 Overview
12.6.2 Financials
12.6.3 Product Portfolio
12.6.4 Recent Developments
12.6.5 Business Strategies
12.7 Henry Schein
12.7.1 Overview
12.7.2 Financials
12.7.3 Product Portfolio
12.7.4 Recent Developments
12.7.5 Business Strategies
12.8 Lifeassay Diagnostics (Pty)
12.8.1 Overview
12.8.2 Financials
12.8.3 Product Portfolio
12.8.4 Recent Developments
12.8.5 Business Strategies
12.9 Lifescan, Inc. (a Johnson & Johnson company)
12.9.1 Overview
12.9.2 Financials
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.9.5 Business Strategies
12.10 Roche Diagnostics
12.10.1 Overview
12.10.2 Financials
12.10.3 Product Portfolio
12.10.4 Recent Developments
12.10.5 Business Strategies
12.11 Siemens Healthcare
12.11.1 Overview
12.11.2 Financials
12.11.3 Product Portfolio
12.11.4 Recent Developments
12.11.5 Business Strategies
12.12 Taidoc Technology Corporation
12.12.1 Overview
12.12.2 Financials
12.12.3 Product Portfolio
12.12.4 Recent Developments
12.12.5 Business Strategies
12.13 Teco Diagnostics
12.13.1 Overview
12.13.2 Financials
12.13.3 Product Portfolio
12.13.4 Recent Developments
12.13.5 Business Strategies
